Literature DB >> 22568947

Irradiation affects cellular properties and Eph receptor expression in human melanoma cells.

Birgit Mosch1, Doreen Pietzsch, Jens Pietzsch.   

Abstract

X-ray irradiation influences metastatic properties of tumor cells and, moreover, metastasis and cellular motility can be modified by members of the Eph receptor/ephrin family of receptor tyrosine kinases. We hypothesized that irradiation-induced changes in cellular properties relevant for metastasis in melanoma cells could be mediated by Eph receptor/ephrin signaling. In this pilot study, we analyzed one pre-metastatic (Mel-Juso) and three metastatic human melanoma (Mel-Juso-L3, A375, and A2058) cells lines and predominantly found anti-metastatic effects of X-ray irradiation with impaired cell growth, clonal growth and motility. Additionally, we observed an irradiation-induced increase in adhesion paralleled by a decrease in migration in Mel-Juso and Mel-Juso-L3 cells and, in part, also in A375 cells. We further demonstrate a decrease of EphA2 both in expression and activity at 7 d after irradiation paralleled by an upregulation of EphA3. Analyzing downstream signaling after irradiation, we detected decreased Src kinase phosphorylation, but unchanged focal adhesion kinase (FAK) phosphorylation, indicating, in part, irradiation-induced downregulation of signaling via the EphA2-Src-FAK axis in melanoma cells. However, to which extent this finding contributes to the modification of metastasis-relevant cellular properties remains to be elucidated.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22568947      PMCID: PMC3499310          DOI: 10.4161/cam.20655

Source DB:  PubMed          Journal:  Cell Adh Migr        ISSN: 1933-6918            Impact factor:   3.405


  67 in total

Review 1.  Mechanisms and functions of Eph and ephrin signalling.

Authors:  Klas Kullander; Rüdiger Klein
Journal:  Nat Rev Mol Cell Biol       Date:  2002-07       Impact factor: 94.444

Review 2.  The ephrins and Eph receptors in angiogenesis.

Authors:  Nikki Cheng; Dana M Brantley; Jin Chen
Journal:  Cytokine Growth Factor Rev       Date:  2002-02       Impact factor: 7.638

Review 3.  Eph-modulated cell morphology, adhesion and motility in carcinogenesis.

Authors:  Sabine H Wimmer-Kleikamp; Martin Lackmann
Journal:  IUBMB Life       Date:  2005-06       Impact factor: 3.885

4.  Particle irradiation suppresses metastatic potential of cancer cells.

Authors:  Toshiyuki Ogata; Teruki Teshima; Kazufumi Kagawa; Yoshio Hishikawa; Yutaka Takahashi; Atsuko Kawaguchi; Yuko Suzumoto; Kumie Nojima; Yoshiya Furusawa; Nariaki Matsuura
Journal:  Cancer Res       Date:  2005-01-01       Impact factor: 12.701

5.  Response of a human melanoma cell line to low and high ionizing radiation.

Authors:  Aleksandra M Ristic-Fira; Danijela V Todorovic; Lela B Koricanac; Ivan M Petrovic; Lucia M Valastro; Pablo G A Cirrone; Luigi Raffaele; Giacomo Cuttone
Journal:  Ann N Y Acad Sci       Date:  2007-01       Impact factor: 5.691

6.  VDR microRNA expression and epigenetic silencing of vitamin D signaling in melanoma cells.

Authors:  S Essa; N Denzer; U Mahlknecht; R Klein; E M Collnot; W Tilgen; J Reichrath
Journal:  J Steroid Biochem Mol Biol       Date:  2010-02-11       Impact factor: 4.292

7.  EphA2 in the early pathogenesis and progression of non-small cell lung cancer.

Authors:  Jennifer M Brannan; Banibrata Sen; Babita Saigal; Ludmila Prudkin; Carmen Behrens; Luisa Solis; Wenli Dong; B Nebiyou Bekele; Ignacio Wistuba; Faye M Johnson
Journal:  Cancer Prev Res (Phila)       Date:  2009-11-24

Review 8.  EPH receptors in cancer.

Authors:  Julio Castaño; Veronica Davalos; Simo Schwartz; Diego Arango
Journal:  Histol Histopathol       Date:  2008-08       Impact factor: 2.303

9.  Regulation of process retraction and cell migration by EphA3 is mediated by the adaptor protein Nck1.

Authors:  Tianjing Hu; Guanfang Shi; Louise Larose; Gonzalo M Rivera; Bruce J Mayer; Renping Zhou
Journal:  Biochemistry       Date:  2009-07-14       Impact factor: 3.162

10.  Ephrin-A5 induces rounding, blebbing and de-adhesion of EphA3-expressing 293T and melanoma cells by CrkII and Rho-mediated signalling.

Authors:  Isobel D Lawrenson; Sabine H Wimmer-Kleikamp; Peter Lock; Simone M Schoenwaelder; Michelle Down; Andrew W Boyd; Paul F Alewood; Martin Lackmann
Journal:  J Cell Sci       Date:  2002-03-01       Impact factor: 5.285

View more
  9 in total

1.  Eph/ephrin signaling in cancer: intricate, puzzling and ... fascinating!

Authors:  Luis Miguel Alonso-Colmenar
Journal:  Cell Adh Migr       Date:  2012-03-01       Impact factor: 3.405

2.  Simultaneous profiling of 194 distinct receptor transcripts in human cells.

Authors:  Byong H Kang; Karin J Jensen; Jaime A Hatch; Kevin A Janes
Journal:  Sci Signal       Date:  2013-08-06       Impact factor: 8.192

3.  Interaction of extracellular S100A4 with RAGE prompts prometastatic activation of A375 melanoma cells.

Authors:  Nadine Herwig; Birgit Belter; Susann Wolf; Cathleen Haase-Kohn; Jens Pietzsch
Journal:  J Cell Mol Med       Date:  2016-03-01       Impact factor: 5.310

4.  miR-26b enhances radiosensitivity of hepatocellular carcinoma cells by targeting EphA2.

Authors:  Qiao Jin; Xiang Jun Li; Pei Guo Cao
Journal:  Iran J Basic Med Sci       Date:  2016-08       Impact factor: 2.699

5.  Overexpression of Receptor Tyrosine Kinase EphB4 Triggers Tumor Growth and Hypoxia in A375 Melanoma Xenografts: Insights from Multitracer Small Animal Imaging Experiments.

Authors:  Christin Neuber; Birgit Belter; Sebastian Meister; Frank Hofheinz; Ralf Bergmann; Hans-Jürgen Pietzsch; Jens Pietzsch
Journal:  Molecules       Date:  2018-02-17       Impact factor: 4.411

6.  A lipid-free and insulin-supplemented medium supports De Novo fatty acid synthesis gene activation in melanoma cells.

Authors:  Su Wu; Anders M Näär
Journal:  PLoS One       Date:  2019-04-10       Impact factor: 3.240

7.  Quantitative Tyrosine Phosphoproteomic Analysis of Resistance to Radiotherapy in Nasopharyngeal Carcinoma Cells.

Authors:  Lin Shen; Zhanzhan Li; Liangfang Shen
Journal:  Cancer Manag Res       Date:  2020-12-09       Impact factor: 3.989

8.  CRISPR/Cas9 Mediated Knockout of Cyclooxygenase-2 Gene Inhibits Invasiveness in A2058 Melanoma Cells.

Authors:  Cathleen Haase-Kohn; Markus Laube; Cornelius K Donat; Birgit Belter; Jens Pietzsch
Journal:  Cells       Date:  2022-02-21       Impact factor: 7.666

9.  miR‑141 inhibits glioma vasculogenic mimicry by controlling EphA2 expression.

Authors:  Guoxiong Li; Min Huang; Yingqian Cai; Yiquan Ke; Yuantao Yang; Xinlin Sun
Journal:  Mol Med Rep       Date:  2018-05-31       Impact factor: 2.952

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.